Robuta

https://www.sharecare.com/hcp/gastroenterology/non-alcoholic-steatohepatitis
15 million people in the U.S. with MASH face increased risk of cirrhosis, hepatocellular carcinoma and liver transplantation.
dx dialoguessilent epidemicliver diseasemashmetabolic